Aripiprazole versus risperidone in the treatment of children and adolescents with tic disorders
Phase 3
- Conditions
- Tic disorder.Tic disorders
- Registration Number
- IRCT201301053930N17
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
children and adolescents aged 6 to 18 years; total score of YGTS more than 21. Exclusion criteria: Marked general medical condition; hypersensitivity to the medications.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Yale global tic severity scale. Timepoint: Every 4 weeks. Method of measurement: interview.
- Secondary Outcome Measures
Name Time Method Adverse effects checklist. Timepoint: every 4 weeks. Method of measurement: checklist.